Last reviewed · How we verify

NCT07437742: SURGENDO

Reproductive Prognosis in Women Seeking Offspring After Medical or Surgical Therapy for Endometriosis

Recruiting now Last updated 27 February 2026
What this trial tests

trial testing PMA in Endometriosis in 650 participants. Currently enrolling.

Timeline
1 October 2024
Primary endpoint
30 March 2026
31 December 2026

Quick facts

Lead sponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment650
Start date1 October 2024
Primary completion30 March 2026
Estimated completion31 December 2026
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Who can join

Adults 18 to 40, female only, with Endometriosis or Fertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to compare the percentage of women with endometriosis who undergo PMA after medical vs surgical treatment and to describe conception patterns, pregnancy rates, and number of live vessels in women seeking offspring with endometriosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07437742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing